Advertisement
Research Article| Volume 103, ISSUE 2, P328-337, February 2014

Download started.

Ok

Genetic variants for type 2 diabetes and new-onset cancer in Chinese with type 2 diabetes

  • R.C.W. Ma
    Correspondence
    Corresponding author at: Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong. Tel.: +852 26323307; fax: +852 26373852.
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong

    Hong Kong Institute of Diabetes and Obesity, Chinese University of Hong Kong, Hong Kong

    Lee Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong
    Search for articles by this author
  • W.Y. So
    Correspondence
    Corresponding author. Tel.: +852 26323129; fax: +852 26373852.
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Search for articles by this author
  • C.H.T. Tam
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Search for articles by this author
  • A.O. Luk
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Search for articles by this author
  • J.S.K. Ho
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Search for articles by this author
  • Y. Wang
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Search for articles by this author
  • V.K. Lam
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Search for articles by this author
  • H.M. Lee
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Search for articles by this author
  • A.P. Kong
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Search for articles by this author
  • P.C. Tong
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Search for articles by this author
  • G. Xu
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong

    Hong Kong Institute of Diabetes and Obesity, Chinese University of Hong Kong, Hong Kong

    Lee Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong
    Search for articles by this author
  • C.C. Chow
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Search for articles by this author
  • Author Footnotes
    1 Present address: Department of Pediatrics, Section on Medical Genetics, Centers for Diabetes Research and Human Genomics, Wake Forest University School of Medicine, USA.
    M.C. Ng
    Footnotes
    1 Present address: Department of Pediatrics, Section on Medical Genetics, Centers for Diabetes Research and Human Genomics, Wake Forest University School of Medicine, USA.
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Search for articles by this author
  • X.L. Yang
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
    Search for articles by this author
  • J.C. Chan
    Affiliations
    Department of Medicine and Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong

    Hong Kong Institute of Diabetes and Obesity, Chinese University of Hong Kong, Hong Kong

    Lee Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong
    Search for articles by this author
  • Author Footnotes
    1 Present address: Department of Pediatrics, Section on Medical Genetics, Centers for Diabetes Research and Human Genomics, Wake Forest University School of Medicine, USA.
Published:January 27, 2014DOI:https://doi.org/10.1016/j.diabres.2013.12.016

      Abstract

      Background

      Diabetes is associated with an increased risk of cancer. This study aimed to evaluate associations between recently reported type 2 diabetes (T2D) susceptibility genetic variants and cancer risk in a prospective cohort of Chinese patients with T2D.

      Methods

      Seven single nucleotide polymorphisms (SNP) in IGF2BP2, CDKAL1, SLC30A8, CDKN2A/B, HHEX and TCF7L2, all identified from genome-wide association studies of T2D, were genotyped in 5900 T2D patients [age mean ± SD = 57 ± 13 years, % males = 46] without any known cancer at baseline. Associations between new-onset of cancer and SNPs were tested by Cox proportional hazard models with adjustment of conventional risk factors.

      Results

      During the mean follow-up period of 8.5 ± 3.3 years, 429 patients (7.3%) developed cancer. Of the T2D-related SNPs, the G-alleles of HHEX rs7923837 (hazard ratio [HR] (95% C.I.) = 1.34 (1.08–1.65); P = 6.7 × 10−3 under dominant model) and TCF7L2 rs290481 (HR (95% C.I.) = 1.16 (1.01–1.33); P = 0.040 under additive model) were positively associated with cancer risk, while the G-allele of CDKAL1 rs7756992 was inversely associated (HR (95% C.I.) = 0.80 (0.65–1.00); P = 0.048 under recessive model). The risk alleles of these significant SNPs exhibited combined effect on increasing cancer risk (per-allele HR (95% C.I.) = 1.25 (1.12–1.39); P = 4.8 × 10−5). The adjusted cancer risk was 2.41 (95% C.I. 1.23–4.69) for patients with four risk alleles comparing to patients without risk allele.

      Conclusions

      T2D-related variants HHEX rs7923837, TCF7L2 rs290481 and CDKAL1 rs7756992 increased cancer risk in patients with diabetes.

      Impact

      Our findings provide novel insights into the pathogenesis of cancer in diabetes.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Diabetes Research and Clinical Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zimmet P.
        • Alberti K.G.
        • Shaw J.
        Global and societal implications of the diabetes epidemic.
        Nature. 2001; 414: 782-787
        • Jee S.H.
        • Ohrr H.
        • Sull J.W.
        • Yun J.E.
        • Ji M.
        • et al.
        Fasting serum glucose level and cancer risk in Korean men and women.
        JAMA. 2005; 293: 194-202
        • Larsson S.C.
        • Orsini N.
        • Wolk A.
        Diabetes mellitus and risk of colorectal cancer: a meta-analysis.
        J Natl Cancer Inst. 2005; 97: 1679-1687
        • Yang X.
        • So W.
        • Ko G.T.
        • Ma R.C.
        • Kong A.P.
        • et al.
        Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus.
        CMAJ. 2008; 179: 427-437
        • Giovannucci E.
        • Harlan D.M.
        • Archer M.C.
        • Bergenstal R.M.
        • Gapstur S.M.
        • et al.
        Diabetes and cancer: a consensus report.
        Diabetes Care. 2010; 33: 1674-1685
        • Seshasai S.R.
        • Kaptoge S.
        • Thompson A.
        • Di Angelantonio E.
        • Gao P.
        • et al.
        Diabetes mellitus, fasting glucose, and risk of cause-specific death.
        N Engl J Med. 2011; 364: 829-841
        • Voight B.F.
        • Scott L.J.
        • Steinthorsdottir V.
        • Morris A.P.
        • Dina C.
        • et al.
        Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis.
        Nat Genet. 2010; 42: 579-589
        • Zeggini E.
        • Scott L.J.
        • Saxena R.
        • Voight B.F.
        • Marchini J.L.
        • et al.
        Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.
        Nat Genet. 2008; 40: 638-645
        • Dupuis J.
        • Langenberg C.
        • Prokopenko I.
        • Saxena R.
        • Soranzo N.
        • et al.
        New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.
        Nat Genet. 2010; 42: 105-116
        • McCarthy M.I.
        Genomics, type 2 diabetes, and obesity.
        N Engl J Med. 2010; 363: 2339-2350
        • Ramachandran A.
        • Ma R.C.
        • Snehalatha C.
        Diabetes in Asia.
        Lancet. 2010; 375: 408-418
        • Helgadottir A.
        • Thorleifsson G.
        • Manolescu A.
        • Gretarsdottir S.
        • Blondal T.
        • et al.
        A common variant on chromosome 9p21 affects the risk of myocardial infarction.
        Science. 2007; 316: 1491-1493
        • Doria A.
        • Wojcik J.
        • Xu R.
        • Gervino E.V.
        • Hauser T.H.
        • et al.
        Interaction between poor glycemic control and 9p21 locus on risk of coronary artery disease in type 2 diabetes.
        JAMA. 2008; 300: 2389-2397
        • Gudmundsson J.
        • Sulem P.
        • Steinthorsdottir V.
        • Bergthorsson J.T.
        • Thorleifsson G.
        • et al.
        Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.
        Nat Genet. 2007; 39: 977-983
        • Folsom A.R.
        • Pankow J.S.
        • Peacock J.M.
        • Bielinski S.J.
        • Heiss G.
        • et al.
        Variation in TCF7L2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) Study.
        Diabetes Care. 2008; 31: 905-909
        • Ma Y.C.
        • Zuo L.
        • Chen J.H.
        Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.
        J Am Soc Nephrol. 2006; 17: 2937-2944
        • Ng M.C.
        • Park K.S.
        • Oh B.
        • Tam C.H.
        • Cho Y.M.
        • et al.
        Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6719 Asians.
        Diabetes. 2008; 57: 2226-2233
        • Purcell S.
        • Neale B.
        • Todd-Brown K.
        • Thomas L.
        • Ferreira M.A.
        • et al.
        PLINK: a tool set for whole-genome association and population-based linkage analyses.
        Am J Hum Genet. 2007; 81: 559-575
        • Purcell S.
        • Cherny S.S.
        • Sham P.C.
        Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.
        Bioinformatics. 2003; 19: 149-150
        • Sladek R.
        • Rocheleau G.
        • Rung J.
        • Dina C.
        • Shen L.
        • et al.
        A genome-wide association study identifies novel risk loci for type 2 diabetes.
        Nature. 2007; 445: 881-885
        • Yang X.
        • So W.Y.
        • Ma R.C.
        • Ko G.T.
        • Kong A.P.
        • et al.
        Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.
        Diabetes Care. 2009; 32: 1826-1832
        • Yang X.
        • Zhao H.
        • Sui Y.
        • Ma R.C.
        • So W.Y.
        • et al.
        Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes.
        Diabetes. 2009; 58: 1518-1525
        • Yang X.
        • Ko G.T.
        • So W.Y.
        • Ma R.C.
        • Yu L.W.
        • et al.
        Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.
        Diabetes. 2010; 59: 1254-1260
        • D’Elia A.V.
        • Tell G.
        • Russo D.
        • Arturi F.
        • Puglisi F.
        • et al.
        Expression and localization of the homeodomain-containing protein HEX in human thyroid tumors.
        J Clin Endocrinol Metab. 2002; 87: 1376-1383
        • Paz H.
        • Lynch M.R.
        • Bogue C.W.
        • Gasson J.C.
        The homeobox gene Hhex regulates the earliest stages of definitive hematopoiesis.
        Blood. 2010; 116: 1254-1262
        • Su J.
        • You P.
        • Zhao J.P.
        • Zhang S.L.
        • Song S.H.
        • et al.
        A potential role for the homeoprotein Hhex in hepatocellular carcinoma progression.
        Med Oncol. 2011;
        • Gaudet M.M.
        • Yang H.P.
        • Bosquet J.G.
        • Healey C.S.
        • Ahmed S.
        • et al.
        No association between FTO or HHEX and endometrial cancer risk.
        Cancer Epidemiol Biomarkers Prev. 2010; 19: 2106-2109
        • van de Wetering M.
        • Sancho E.
        • Verweij C.
        • de Lau W.
        • Oving I.
        • et al.
        The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.
        Cell. 2002; 111: 241-250
        • Tuupanen S.
        • Turunen M.
        • Lehtonen R.
        • Hallikas O.
        • Vanharanta S.
        • et al.
        The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.
        Nat Genet. 2009; 41: 885-890
        • Zhao J.
        • Schug J.
        • Li M.
        • Kaestner K.H.
        • Grant S.F.
        Disease-associated loci are significantly over-represented among genes bound by transcription factor 7-like 2 (TCF7L2) in vivo.
        Diabetologia. 2010; 53: 2340-2346
        • Slattery M.L.
        • Folsom A.R.
        • Wolff R.
        • Herrick J.
        • Caan B.J.
        • et al.
        Transcription factor 7-like 2 polymorphism and colon cancer.
        Cancer Epidemiol Biomarkers Prev. 2008; 17: 978-982
        • Frayling T.M.
        • Colhoun H.
        • Florez J.C.
        A genetic link between type 2 diabetes and prostate cancer.
        Diabetologia. 2008; 51: 1757-1760
        • Kasper J.S.
        • Giovannucci E.
        A meta-analysis of diabetes mellitus and the risk of prostate cancer.
        Cancer Epidemiol Biomarkers Prev. 2006; 15: 2056-2062
        • Meyer T.E.
        • Boerwinkle E.
        • Morrison A.C.
        • Volcik K.A.
        • Sanderson M.
        • et al.
        Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study.
        Cancer Epidemiol Biomarkers Prev. 2010; 19: 558-565
        • Stevens V.L.
        • Ahn J.
        • Sun J.
        • Jacobs E.J.
        • Moore S.C.
        • et al.
        HNF1B and JAZF1 genes, diabetes, and prostate cancer risk.
        Prostate. 2010; 70: 601-607
        • So H.C.
        • Gui A.H.
        • Cherny S.S.
        • Sham P.C.
        Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases.
        Genet Epidemiol. 2011; 35: 310-317
        • Hirsch H.A.
        • Iliopoulos D.
        • Joshi A.
        • Zhang Y.
        • Jaeger S.A.
        • et al.
        A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases.
        Cancer Cell. 2010; 17: 348-361